Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02GMU
|
||||
| Former ID |
DNC013284
|
||||
| Drug Name |
Tyr-Pro-3,5Dmp-Phe-NH2
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528832] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C34H41N5O5
|
||||
| Canonical SMILES |
CC1=CC(=CC(=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3C<br />CCN3C(=O)C(CC4=CC=C(C=C4)O)N)C
|
||||
| InChI |
1S/C34H41N5O5/c1-21-15-22(2)17-25(16-21)20-29(32(42)37-28(31(36)41)19-23-7-4-3-5-8-23)38-33(43)30-9-6-14-39(30)34(44)27(35)18-24-10-12-26(40)13-11-24/h3-5,7-8,10-13,15-17,27-30,40H,6,9,14,18-20,35H2,1-2H3,(H2,36,41)(H,37,42)(H,38,43)/t27-,28-,29-,30-/m0/s1
|
||||
| InChIKey |
WGUOAUNVYIRMQJ-KRCBVYEFSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528832] | |
| Delta-type opioid receptor | Target Info | Inhibitor | [528832] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.